This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Optimizing Pazopanib Exposure in RCC Patients thro...
Clinical trial

Optimizing Pazopanib Exposure in RCC Patients through Therapeutic Drug Monitoring Followed by Intrapatient Dose Escalation

Read time: 1 mins
Last updated:5th Mar 2013
Determine if in patients with a Pazopanib plasma trough level of ? 20 ?g/mL a plasma trough level of > 20 ?g/mL can be achieved by dose escalation.
Category Value
Study start date 2013-03-05

View full details